Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
180 participants
OBSERVATIONAL
2025-10-16
2026-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection of Bone Marrow Metastases With Magnetic Resonance Imaging
NCT03876392
A Study on the Diagnostic Value of 99mTc-FAPI Quantitative SPECT/CT Imaging in Adult Solitary Bone Lesions
NCT07114211
18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
NCT01927939
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365
Role of SPECT/CT of Bone Scan in Charactarization of Bone Lesions
NCT07248033
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group PET/CT
Whole body PET/CT foundation model
No interventions assigned to this group
Group CT
Whole body CT foundation model
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over 18 years
Exclusion Criteria
* Severe coagulation disorders that cannot be corrected
* Random blood glucose \> 11.1 mmol/L
* Refuse for pathological confirmation or follow-up
* Extremely debilitated patients or those unable to cooperate
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai 6th People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhao Hui
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PET/CT MODEL 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.